2025
ICD-10-CM
Diagnosis
Code

T45.AX5D Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter

  • Billable
  • POA Exempt
  • 2025–2025

T45.AX5D is a new billable/specific and POA-exempt diagnosis code introduced in the 2025 ICD-10-CM used to classify the following condition: Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter.

Versions

  1. 2025

    New code